Get the Stockscreener App
1.04
0.97%
0.01
Aditxt Inc stock is traded at $1.04, with a volume of 135.74K.
It is up +0.97% in the last 24 hours and down -16.13% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
See More
Previous Close:
$1.03
Open:
$1.02
24h Volume:
135.74K
Relative Volume:
0.17
Market Cap:
$5.15M
Revenue:
$212.10K
Net Income/Loss:
$-40.19M
P/E Ratio:
-0.000196
EPS:
-5313.2836
Net Cash Flow:
$-13.92M
1W Performance:
+1.96%
1M Performance:
-16.13%
6M Performance:
-95.45%
1Y Performance:
-99.99%
1-Day Range:
$1.01
$1.07
1-Week Range:
$0.9801
$1.18
52-Week Range:
$0.81
$9,800.00
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
1.04 | 2.58M | 212.10K | -40.19M | -13.92M | -5,313.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Aditxt Inc Stock (ADTX) Latest News
Aditxt Inc. Nearing Breakout Level After BounceBond Market & Growth Focused Investment Plans - thegnnews.com
FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis - Benzinga
📈 US spot BTC and ETH ETFs set a record volume of US$39.3 billion; Crypto.com will provide custodial services to VivoPower and Aditxt - Crypto.com
Aditxt 2025 Q2 Earnings Sustained Losses Amid Revenue Decline - AInvest
Price Channel Expanding on Aditxt Inc.’s ChartJuly 2025 Patterns & Safe Entry Zone Identification - newsyoung.net
How Aditxt Inc. stock performs during market volatilityJuly 2025 Earnings & Low Drawdown Momentum Ideas - sundaytimes.kr
Aditxt, Inc. SEC 10-Q Report - TradingView
Evofem Biosciences reports Q2 2025 net sales of $4.8mln, improved loss from operations. - AInvest
Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update - MarketScreener
Crypto.com to Provide Custody Services for Proposed Aditxt Digital Asset Treasury - Crypto.com
Aditxt Engages Spartan Capital for Pearsanta IPO - The Globe and Mail
Biotech firm Aditxt secures assets with Crypto custody - Interesting Engineering
Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio Initiative - MarketScreener
Crypto.com to provide custody for Aditxt’s planned digital treasury - Investing.com
Aditxt signs custody agreement with Crypto.com for digital asset treasury - Investing.com Canada
Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio™ Initiative - Business Wire
Aditxt Announces Board Changes Ahead of Annual Meeting - TipRanks
Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference - MarketScreener
Aditxt Shares Are Trading Higher After the Company Announced It Submitted an Application for Four New Federal Funding Opportunities. - 富途牛牛
Is Aditxt Inc. a growth stock or a value stockBuild a diversified portfolio for steady profits - Jammu Links News
What is the risk reward ratio of investing in Aditxt Inc. stockGet professional guidance for market timing - Jammu Links News
Aditxt Inc. Chart Enters High Volatility ZoneLow Drawdown Real Time Trading Tips Shared - beatles.ru
What analysts say about Aditxt Inc. stockFree Stock Market Forecast Reports - Jammu Links News
Why is Aditxt Inc. stock attracting strong analyst attentionCapitalize on emerging investment opportunities - Jammu Links News
What are Aditxt Inc. company’s key revenue driversMaximize your returns with smart trade entries - Jammu Links News
How volatile is Aditxt Inc. stock compared to the marketUnlock expert insights for smarter investing - Jammu Links News
What catalysts could drive Aditxt Inc. stock higher in 2025Exceptional growth trajectory - Jammu Links News
Is Aditxt Inc. a good long term investmentConsistent high-yield stocks - Jammu Links News
What is Aditxt Inc. company’s growth strategyUnlock expert trading strategies for growth - Jammu Links News
What is the dividend policy of Aditxt Inc. stockDiscover investment plans that deliver results - Jammu Links News
What are analysts’ price targets for Aditxt Inc. in the next 12 monthsUnlock powerful stock screening tools today - Jammu Links News
Is it the right time to buy Aditxt Inc. stockMaximize returns with effective portfolio management - Jammu Links News
How many analysts rate Aditxt Inc. as a “Buy”Low Risk Recommendation With High Returns - jammulinksnews.com
Should I hold or sell Aditxt Inc. stock in 2025Expert Picks Target Finder For Consistent Profits - jammulinksnews.com
Aditxt subsidiary Pearsanta engages Spartan Capital for planned IPO - Investing.com Australia
Aditxt subsidiary Pearsanta engages Spartan Capital for planned IPO By Investing.com - Investing.com India
Breakthrough Cancer Detection Company Pearsanta Announces IPO Plans to Scale Early Disease Detection Platform - Stock Titan
Published on: 2025-07-29 11:27:13 - metal.it
How strong is Aditxt Inc. company’s balance sheetBuild a winning investment strategy today - Jammu Links News
How does Aditxt Inc. generate profit in a changing economyMarket Forecast Opportunities Backed By Experts - Jammu Links News
Does Aditxt Inc. stock perform well during market downturnsTake advantage of unprecedented market momentum - Jammu Links News
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aditxt Inc Stock (ADTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Oct 16 '24 |
Sale |
1.17 |
25,534 |
29,875 |
0 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):